Skip to main content
TipRanks
Go Ultimate75% OFF

Pharmarise Holdings Corp. (2796) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Pharmarise Holdings Corp. has a market cap or net worth of JPY 5.96B. The enterprise value is JPY 16.70B.

Market Cap
JPY 5.96B
Enterprise Value
JPY 16.70B

Share Statistics

Pharmarise Holdings Corp. has 12,069,231 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
12,069,231
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Pharmarise Holdings Corp.’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 0.64%.

Return on Equity (ROE)
0.02
Return on Assets (ROA)
0.00
Return on Invested Capital (ROIC)
0.64%
Return on Capital Employed (ROCE)
0.05
Revenue Per Employee
34.23M
Profits Per Employee
55.64K
Employee Count
2,031
Asset Turnover
2.13
Inventory Turnover
21.65

Valuation Ratios

The current PE Ratio of Pharmarise Holdings Corp. is 59.72. Pharmarise Holdings Corp.’s PEG ratio is 0.16.

PE Ratio
59.72
PS Ratio
0.08
PB Ratio
0.88
Price to FCF
0.00
Price to Operating Cash Flow
0.00
PEG Ratio
0.16

Income Statement

In the last 12 months, Pharmarise Holdings Corp. had revenue of 69.51B and earned 113.00M in profits. Earnings per share was 9.95.

Revenue
69.51B
Gross Profit
8.64B
Operating Income
980.00M
Pretax Income
698.00M
Net Income
113.00M
EBITDA
2.58B
Earnings Per Share (EPS)
9.95

Cash Flow

In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.

Operating Cash Flow
0
Free Cash Flow
0
Free Cash Flow per Share
0.00

Dividends & Yields

Pharmarise Holdings Corp. pays an annual dividend of JPY 14.00, resulting in a dividend yield of 2.76%

Dividend Per Share
JPY 14.00
Dividend Yield
2.76%
Payout Ratio
-165.68%
Free Cash Flow Yield
0.00%
Earnings Yield
1.63%

Stock Price Statistics

Beta
0.09
52-Week Price Change
-5.59%
50-Day Moving Average
505.44
200-Day Moving Average
502.12
Relative Strength Index (RSI)
53.93
Average Volume (3m)
6,380

Important Dates

Pharmarise Holdings Corp. upcoming earnings date is Dec 17, 2026, TBA (Not Confirmed).

Last Earnings Date
Sep 17, 2026
Next Earnings Date
Dec 17, 2026
Ex-Dividend Date
May 29, 2025

Financial Position

Pharmarise Holdings Corp. as a current ratio of 0.94, with Debt / Equity ratio of 221.46%

Current Ratio
0.94
Quick Ratio
0.74
Debt to Market Cap
2.52
Net Debt to EBITDA
3.54
Interest Coverage Ratio
3.44

Taxes

In the past 12 months, Pharmarise Holdings Corp. has paid 591.00M in taxes.

Income Tax
591.00M
Effective Tax Rate
0.85

Enterprise Valuation

Pharmarise Holdings Corp. EV to EBITDA ratio is 6.68, with an EV/FCF ratio of 0.00.

EV to Sales
0.24
EV to EBITDA
6.68
EV to Free Cash Flow
0.00
EV to Operating Cash Flow
0.00

Balance Sheet

Pharmarise Holdings Corp. has JPY 2.94B in cash and marketable securities with JPY 13.83B in debt, giving a net cash position of -JPY 10.89B billion.

Cash & Marketable Securities
JPY 2.94B
Total Debt
JPY 13.83B
Net Cash
-JPY 10.89B
Net Cash Per Share
-JPY 902.21
Tangible Book Value Per Share
-JPY 60.51

Margins

Gross margin is 12.31%, with operating margin of 1.28%, and net profit margin of 0.14%.

Gross Margin
12.31%
Operating Margin
1.28%
Pretax Margin
0.92%
Net Profit Margin
0.14%
EBITDA Margin
3.58%
EBIT Margin
1.25%

Analyst Forecast

The average price target for Pharmarise Holdings Corp. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
7.64%
EPS Growth Forecast
―

Scores

Smart Score
―
AI Score
56